celecoxib has been researched along with Hormone-Dependent Neoplasms in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Postmenopausal metastatic breast cancer patients without previous adjuvant AI treatment received exemestane 25 mg/days plus either celecoxib 400 mg twice daily or placebo." | 9.14 | Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. ( Bachelot, T; Crétin, J; Debled, M; Delozier, T; Falandry, C; Freyer, G; Mauriac, L; Mille, D; Pujade-Lauraine, E; Romestaing, P; You, B, 2009) |
| " Postmenopausal metastatic breast cancer patients without previous adjuvant AI treatment received exemestane 25 mg/days plus either celecoxib 400 mg twice daily or placebo." | 5.14 | Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study. ( Bachelot, T; Crétin, J; Debled, M; Delozier, T; Falandry, C; Freyer, G; Mauriac, L; Mille, D; Pujade-Lauraine, E; Romestaing, P; You, B, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falandry, C | 1 |
| Debled, M | 1 |
| Bachelot, T | 1 |
| Delozier, T | 1 |
| Crétin, J | 1 |
| Romestaing, P | 1 |
| Mille, D | 1 |
| You, B | 1 |
| Mauriac, L | 1 |
| Pujade-Lauraine, E | 1 |
| Freyer, G | 1 |
| Woditschka, S | 1 |
| Haag, JD | 1 |
| Sullivan, R | 1 |
| Gould, MN | 1 |
| Glück, S | 1 |
| Zheng, X | 1 |
| Cui, XX | 1 |
| Gao, Z | 1 |
| Zhao, Y | 1 |
| Lin, Y | 1 |
| Shih, WJ | 1 |
| Huang, MT | 1 |
| Liu, Y | 1 |
| Rabson, A | 1 |
| Reddy, B | 1 |
| Yang, CS | 1 |
| Conney, AH | 1 |
| Abedinpour, P | 1 |
| Baron, VT | 1 |
| Welsh, J | 1 |
| Borgström, P | 1 |
| Ellis, MJ | 1 |
| Carles, J | 1 |
| Font, A | 1 |
| Mellado, B | 1 |
| Domenech, M | 1 |
| Gallardo, E | 1 |
| González-Larriba, JL | 1 |
| Catalan, G | 1 |
| Alfaro, J | 1 |
| Gonzalez Del Alba, A | 1 |
| Nogué, M | 1 |
| Lianes, P | 1 |
| Tello, JM | 1 |
| Dirix, LY | 1 |
| Ignacio, J | 1 |
| Nag, S | 1 |
| Bapsy, P | 1 |
| Gomez, H | 1 |
| Raghunadharao, D | 1 |
| Paridaens, R | 1 |
| Jones, S | 1 |
| Falcon, S | 1 |
| Carpentieri, M | 1 |
| Abbattista, A | 1 |
| Lobelle, JP | 1 |
1 review available for celecoxib and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormona | 2010 |
3 trials available for celecoxib and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Aromatase I | 2009 |
Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Celecoxib; Dis | 2007 |
Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Area | 2008 |
4 other studies available for celecoxib and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Bexarotene; Carcinoma | 2009 |
Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence.
Topics: Androgens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Antine | 2010 |
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
Topics: Androgen Antagonists; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Celecoxib; | 2011 |
Neoadjuvant endocrine therapy as a drug development strategy.
Topics: Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Celecoxib; Clinic | 2004 |